---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-012182"
form_type: "8-K"
ticker: "ICCC"
cik: "0000811641"
company_name: "IMMUCELL CORP /DE/"
filed_at: "2026-04-14T23:59:59+00:00"
generated_at: "2026-05-15T06:29:43.643943+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# ImmuCell appoints two new independent directors; three directors retire effective April 15, 2026

## Summary
- Bryan Gathagan, Michael Brigham, and Bobbi Jo Brockmann retire from board effective April 15, 2026.
- Gilles Guillemette DVM and Anthony DiMarco Ph.D. elected as new directors effective same date.
- Board moves to 7 members with 6 independent directors; CEO remains only non-independent.
- New Strategy & Technology Committee formed; Guillemette chairs it; DiMarco serves on it.
- Guillemette has 30+ years animal health executive experience; DiMarco 40 years biologics R&D.

## SEC filing metadata
- accession: 0001437749-26-012182
- form_type: 8-K
- ticker: ICCC
- cik: 0000811641
- company_name: IMMUCELL CORP /DE/
- filed_at: 2026-04-14T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/811641/000143774926012182/0001437749-26-012182-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/811641/000143774926012182/iccc20260413_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-012182
- JSON: https://secwatch.observer/filing/0001437749-26-012182.json
- Plain text: https://secwatch.observer/filing/0001437749-26-012182.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.